Literature DB >> 35031884

Histopathological predictors of progression-free survival in atypical meningioma: a single-center retrospective cohort and meta-analysis.

Min-Sung Kim1, Se-Woong Chun2, Yun-Sik Dho3, Youngbeom Seo4, Joo Ho Lee5, Jae Kyung Won6, Jin Wook Kim1, Chul-Kee Park1, Sung-Hye Park6, Yong Hwy Kim7.   

Abstract

To determine the prognostic significance of histopathological features included in the diagnostic criteria of atypical meningioma for progression-free survival (PFS). We performed a retrospective cohort study and meta-analysis. Brain invasion, mitotic index, spontaneous necrosis, sheeting, prominent nucleoli, high cellularity, and small cells were the histopathological features of interest. The data from 25 studies involving 3590 patients including our cohort (n = 262) were included. The pooled HR of mitotic index at a cutoff value of 4 showed no statical significance in the gross analysis (pooled HR, 1.09; 95% CI 0.61-1.96; p = 0.7699). Furthermore, it failed to prognosticate PFS in other pooled analyses. For brain invasion, no consistent association with the progression was found in each pooled analysis according to the included studies. Among the remaining five atypical features, spontaneous necrosis, sheeting, and prominent nucleoli showed a significant correlation with PFS in the gross analysis. In the analysis that pooled the HRs from the multivariate analyses, only spontaneous necrosis had significant association with PFS. The available evidence supports that the current cutoff value of mitotic index for diagnosing atypical meningioma might be improper to have prognostic value. The prognostic significance of brain invasion also needs further evaluation.
© 2021. The Author(s) under exclusive licence to The Japan Society of Brain Tumor Pathology.

Entities:  

Keywords:  Atypical meningioma; Gross total resection; Prognostic factor; Progression-free survival; Recurrence

Mesh:

Year:  2022        PMID: 35031884     DOI: 10.1007/s10014-021-00419-w

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  47 in total

1.  Brain invasion in otherwise benign meningiomas does not predict tumor recurrence.

Authors:  Peter Baumgarten; Florian Gessler; Jens Schittenhelm; Marco Skardelly; Dominique S Tews; Christian Senft; Maika Dunst; Lioba Imoehl; Karl H Plate; Marlies Wagner; Joachim P Steinbach; Volker Seifert; Michel Mittelbronn; Patrick N Harter
Journal:  Acta Neuropathol       Date:  2016-07-27       Impact factor: 17.088

2.  How to perform a meta-analysis with R: a practical tutorial.

Authors:  Sara Balduzzi; Gerta Rücker; Guido Schwarzer
Journal:  Evid Based Ment Health       Date:  2019-09-28

3.  Histopathological features to define atypical meningioma: What does really matter for prognosis?

Authors:  Valeria Barresi; Simona Lionti; Samuel Caliri; Maria Caffo
Journal:  Brain Tumor Pathol       Date:  2018-04-18       Impact factor: 3.298

4.  World Health Organization Grade II Meningioma: A 10-Year Retrospective Study for Recurrence and Prognostic Factor Assessment.

Authors:  Charles Champeaux; Laurence Dunn
Journal:  World Neurosurg       Date:  2016-02-02       Impact factor: 2.104

5.  The histopathological spectrum of human meningiomas.

Authors:  Thomas Backer-Grøndahl; Bjørnar H Moen; Sverre H Torp
Journal:  Int J Clin Exp Pathol       Date:  2012-03-25

6.  Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.

Authors:  Manish K Aghi; Bob S Carter; Garth R Cosgrove; Robert G Ojemann; Sepideh Amin-Hanjani; Robert L Martuza; William T Curry; Fred G Barker
Journal:  Neurosurgery       Date:  2009-01       Impact factor: 4.654

7.  Pathologic Predictors of Local Recurrence in Atypical Meningiomas Following Gross Total Resection.

Authors:  Olivia Claire Barrett; James R Hackney; Andrew M McDonald; Christopher D Willey; Markus Bredel; John B Fiveash
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-09-22       Impact factor: 7.038

8.  Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome.

Authors:  Annamaria Biczok; Christine Jungk; Rupert Egensperger; Andreas von Deimling; Bogdana Suchorska; Joerg C Tonn; Christel Herold-Mende; Christian Schichor
Journal:  J Neurooncol       Date:  2019-11-11       Impact factor: 4.130

9.  Adjuvant Radiotherapy Versus Watchful Waiting for World Health Organization Grade II Atypical Meningioma: A Single-Institution Experience.

Authors:  David P Bray; Joseph W Quillin; Robert H Press; Yilin Yang; Zhengjia Chen; Bree R Eaton; Jeffrey J Olson
Journal:  Neurosurgery       Date:  2021-04-15       Impact factor: 4.654

10.  The prognostic significance of clinicopathological features in meningiomas: Microscopic brain invasion can predict patient outcome in otherwise benign meningiomas.

Authors:  Rouzbeh Banan; Merle Abbetmeier-Basse; Bujung Hong; Claudia A Dumitru; Felix Sahm; Makoto Nakamura; Joachim K Krauss; Christian Hartmann
Journal:  Neuropathol Appl Neurobiol       Date:  2021-02-25       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.